Cellular macromolecules in neovascular endothelium

Cellular macromolecules in neovascular endothelium refers to the collective group of lipids, proteins, and nucleic acids within the endothelial cells of newly formed, pathological blood vessels. These macromolecules serve as the primary site of damage for photodynamic therapy (PDT) agents like verteporfin (DrugBank DB00437). In the presence of oxygen and specific wavelengths of light, these drugs generate highly reactive oxygen species (ROS), such as singlet oxygen, which induce non-specific oxidative damage to the cell membranes and internal structures of the neovascular endothelium (FDA Visudyne Label). This localized destruction leads to thrombus formation, vessel occlusion, and the subsequent regression of pathological neovascularization (PubMed PMID: 11064414). This therapeutic approach is primarily utilized in the treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration (AMD) and other ocular conditions. Unlike targeted biologics that inhibit specific growth factors, this target represents a physical substrate for light-induced cytotoxic reactions.

Other names

Neovascular endothelial macromoleculesEndothelial cellular componentsLipids, proteins, and nucleic acids of the neovascular endotheliumPhotosensitizer targets in neovascularization

Photodynamic therapy (PDT) involves the light-induced activation of a photosensitizer to generate reactive oxygen species (ROS), which cause non-specific oxidative damage to cellular macromolecules, leading to cell death and vessel occlusion.